ES2108234T3 - Composicion farmaceutica que contiene un guanidinotiazol y antiacidos. - Google Patents
Composicion farmaceutica que contiene un guanidinotiazol y antiacidos.Info
- Publication number
- ES2108234T3 ES2108234T3 ES93309611T ES93309611T ES2108234T3 ES 2108234 T3 ES2108234 T3 ES 2108234T3 ES 93309611 T ES93309611 T ES 93309611T ES 93309611 T ES93309611 T ES 93309611T ES 2108234 T3 ES2108234 T3 ES 2108234T3
- Authority
- ES
- Spain
- Prior art keywords
- guanidinotiazole
- acids
- pharmaceutical composition
- composition containing
- effective amount
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000002253 acid Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 230000001458 anti-acid effect Effects 0.000 abstract 2
- 208000018522 Gastrointestinal disease Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/12—Magnesium silicate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/08—Oxides; Hydroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/10—Carbonates; Bicarbonates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/245—Bismuth; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/42—Phosphorus; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Abstract
UN TIPO DE DOSIS ORAL SOLIDA PARA EL TRATAMIENTO DE TRASTORNOS GASTROINTESTINALES QUE CONTIENE UNA CANTIDAD TERAPEUTICAMENTE EFECTIVA DE UNA CANTIDAD TERAPEUTICAMENTE EFECTIVA DE UN COMPUESTO DE GUANIDINOTIAZOL; Y UNA CANTIDAD TERAPEUTICAMENTE EFECTIVA DE UN ANTIACIDO EN DONDE LA SUSTANCIA FARMACEUTICA Y EL ANTIACIDO SE SEPARAN MEDIANTE UNA BARRERA SUSTANCIALMENTE IMPERMEABLE AL ANTACIDO.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US98392392A | 1992-12-01 | 1992-12-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2108234T3 true ES2108234T3 (es) | 1997-12-16 |
Family
ID=25530183
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES93309611T Expired - Lifetime ES2108234T3 (es) | 1992-12-01 | 1993-12-01 | Composicion farmaceutica que contiene un guanidinotiazol y antiacidos. |
Country Status (9)
Country | Link |
---|---|
US (1) | US5817340A (es) |
EP (1) | EP0600725B1 (es) |
AT (1) | ATE158176T1 (es) |
BR (1) | BR1100490A (es) |
CA (1) | CA2110313C (es) |
DE (1) | DE69313983T2 (es) |
DK (1) | DK0600725T3 (es) |
ES (1) | ES2108234T3 (es) |
GR (1) | GR1002397B (es) |
Families Citing this family (70)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GR1002332B (el) * | 1992-05-21 | 1996-05-16 | Mcneil-Ppc Inc. | Νεες φαρμακευτικες συνθεσεις που περιεχουν σιμεθεικονη. |
DE4444052A1 (de) * | 1994-12-10 | 1996-06-13 | Rhone Poulenc Rorer Gmbh | Pharmazeutische, oral anwendbare Zubereitung |
EP0867191A4 (en) * | 1995-11-27 | 2000-01-05 | Yamanouchi Pharma Co Ltd | MEDICINE COMPOSITION |
SE9600071D0 (sv) † | 1996-01-08 | 1996-01-08 | Astra Ab | New oral formulation of two active ingredients I |
CA2267503C (en) * | 1996-10-04 | 2002-04-30 | Merck & Co., Inc. | Methods and compositions for preventing and treating heartburn |
US5989588A (en) * | 1996-10-04 | 1999-11-23 | Merck & Co., Inc. | Methods and compositions for preventing and treating heartburn |
JP3001440B2 (ja) * | 1996-11-25 | 2000-01-24 | 日本電気通信システム株式会社 | 仮想lan方式 |
GB9720061D0 (en) * | 1997-09-19 | 1997-11-19 | Crosfield Joseph & Sons | Metal compounds as phosphate binders |
CN1152717C (zh) * | 1997-09-30 | 2004-06-09 | 第一制药株式会社 | 口服给药制剂 |
US6232351B1 (en) * | 1998-05-22 | 2001-05-15 | Amway Corporation | Co-processed botanical plant composition |
AU1453600A (en) * | 1998-11-04 | 2000-05-22 | Mcneil-Ppc, Inc. | Solid oral dosage forms containing alginic acid and famotidine |
US6270807B1 (en) | 1999-03-02 | 2001-08-07 | L. Perrigo Company | Taste-masked pharmaceutical composition |
US6759062B2 (en) | 2000-02-23 | 2004-07-06 | Bioselect Innovations, Inc. | Composition and method for treating the effects of diseases and maladies |
US6841544B2 (en) * | 2000-02-23 | 2005-01-11 | Bioselect Innovations, Inc. | Composition and method for treating the effects of diseases and maladies |
US6793942B2 (en) | 2000-02-23 | 2004-09-21 | Bioselect Innovations, Inc. | Composition and method for treating the effects of diseases and maladies |
US6787164B2 (en) | 2000-02-23 | 2004-09-07 | Bioselect Innovations, Inc. | Composition and method for treating the effects of diseases and maladies |
US6551617B1 (en) * | 2000-04-20 | 2003-04-22 | Bristol-Myers Squibb Company | Taste masking coating composition |
US8206741B2 (en) | 2001-06-01 | 2012-06-26 | Pozen Inc. | Pharmaceutical compositions for the coordinated delivery of NSAIDs |
US7101573B2 (en) * | 2001-09-28 | 2006-09-05 | Mcneil-Pcc, Inc. | Simethicone solid oral dosage form |
US6998480B2 (en) | 2002-03-08 | 2006-02-14 | Tate & Lyle Public Limited Company | Process for improving sucralose purity and yield |
US7049435B2 (en) | 2002-03-08 | 2006-05-23 | Tate & Lyle Public Limited Company | Extractive methods for purifying sucralose |
US20030203027A1 (en) * | 2002-04-26 | 2003-10-30 | Ethicon, Inc. | Coating technique for deposition of drug substance on a substrate |
US6663892B1 (en) * | 2002-08-19 | 2003-12-16 | L. Perrigo Company | Multiple portion tablet |
US7713547B2 (en) | 2004-05-21 | 2010-05-11 | Accu-Break Pharmaceuticals, Inc. | Method of administering a partial dose of a segmented pharmaceutical tablet |
US7622137B2 (en) * | 2004-05-21 | 2009-11-24 | Accu-Break Technologies, Inc. | Dosage forms contained within a capsule or sachet |
US7838031B2 (en) | 2004-05-21 | 2010-11-23 | Lawrence Solomon | Method of administering a partial dose using a segmented pharmaceutical tablet |
US7318935B2 (en) * | 2004-05-21 | 2008-01-15 | Accu-Break Technologies, Inc. | Pharmaceutical tablets with active and inactive segments |
US7329418B2 (en) * | 2004-05-21 | 2008-02-12 | Accu Break Technologies, Inc. | Pharmaceutical tablets having height greater than width |
ES2439572T3 (es) * | 2004-05-21 | 2014-01-23 | Accu-Break Technologies, Inc. | Comprimidos farmacéuticos de liberación inmediata de mayor altura que anchura |
US7780985B2 (en) * | 2005-07-12 | 2010-08-24 | Accu-Break Technologies, Inc. | Tablets having a printed separation mark to guide breaking |
KR100714616B1 (ko) * | 2005-06-23 | 2007-05-07 | 삼성전기주식회사 | 지수 함수 발생기 및 이를 이용한 가변 이득 증폭기 |
CN100493499C (zh) * | 2005-10-14 | 2009-06-03 | 四川泰华堂制药有限公司 | 制备复方法莫替丁咀嚼片的方法 |
WO2007058660A1 (en) * | 2005-11-18 | 2007-05-24 | Accu-Break Technologies, Inc. | Segmented pharmaceutical dosage forms |
US7351853B2 (en) * | 2006-01-23 | 2008-04-01 | Albion Advanced Nutrition | Method of manufacturing a granular mineral composition |
MY157620A (en) * | 2006-01-31 | 2016-06-30 | Cytochroma Dev Inc | A granular material of a solid water-soluble mixed metal compound capable of binding phosphate |
WO2007090113A2 (en) | 2006-02-01 | 2007-08-09 | Weg Stuart L | Use of antifungal compositions to treat upper gastrointestinal conditions |
US20070237815A1 (en) * | 2006-04-06 | 2007-10-11 | Lawrence Solomon | Dosage forms and methods comprising amlodipine and chlorthalidone |
GB0714670D0 (en) * | 2007-07-27 | 2007-09-05 | Ineos Healthcare Ltd | Use |
GB0720220D0 (en) * | 2007-10-16 | 2007-11-28 | Ineos Healthcare Ltd | Compound |
AR070082A1 (es) * | 2008-01-04 | 2010-03-10 | Tate & Lyle Technology Ltd | Metodo para la produccion de sucralosa |
WO2009095210A1 (en) * | 2008-01-31 | 2009-08-06 | Bayer Consumer Care Ag | Composition comprising an antacid and a h2-antagonists |
US8476424B2 (en) * | 2008-03-20 | 2013-07-02 | Tate & Lyle Technology Limited | Removal of acids from tertiary amide solvents |
US8436157B2 (en) * | 2008-03-26 | 2013-05-07 | Tate & Lyle Technology Limited | Method for the production of sucralose |
AR071134A1 (es) * | 2008-04-03 | 2010-05-26 | Tate & Lyle Technology Ltd | Cristalizacion de sucralosa a partir de chorros que contienen sucralosa |
US8212022B2 (en) * | 2008-04-03 | 2012-07-03 | Tate & Lyle Technology Limited | Effect of carbohydrate concentration on sucralose extraction efficiency |
US8497367B2 (en) * | 2008-04-03 | 2013-07-30 | Tate & Lyle Technology Limited | Sucralose purification process |
US20090259036A1 (en) * | 2008-04-03 | 2009-10-15 | Tate & Lyle Technology Limited | Extraction of less polar impurities from sucralose containing aqueous feed streams |
KR20110079641A (ko) | 2008-09-09 | 2011-07-07 | 아스트라제네카 아베 | 제약 조성물을 이를 필요로 하는 환자에게 전달하는 방법 |
US8058296B2 (en) * | 2008-11-25 | 2011-11-15 | Richard Tokunaga | Treatment and prevention of deleterious effects associated with alcohol consumption |
CA2748728C (en) * | 2009-01-05 | 2017-01-03 | Mcneil-Ppc, Inc. | Tablet containing cetirizine, pseudoephedrine, and naproxen containing a barrier layer |
US8246988B2 (en) * | 2009-01-05 | 2012-08-21 | Mcneil-Ppc, Inc. | Three layer tablet containing cetirizine, pseudoephedrine, and naproxen |
US8252330B2 (en) * | 2009-01-05 | 2012-08-28 | Mcneil-Ppc, Inc. | Tablet containing coated particles of cetirizine, pseudoephedrine, and/or naproxen |
GB2469158B (en) | 2009-03-31 | 2011-09-28 | Peter J Seaberg | Base-assisted formation of tin-sucrose adducts |
SG176724A1 (en) | 2009-06-25 | 2012-01-30 | Astrazeneca Ab | Method for treating a patient at risk for developing an nsaid-associated ulcer |
GB0913525D0 (en) | 2009-08-03 | 2009-09-16 | Ineos Healthcare Ltd | Method |
GB2474310B (en) | 2009-10-12 | 2012-02-29 | Tate & Lyle Technology Ltd | Process for the production of sucrose-6-ester |
GB2474311B (en) | 2009-10-12 | 2012-10-17 | Tate & Lyle Technology Ltd | Low temperature, single solvent process for the production of sucrose-6-ester |
GB201001779D0 (en) | 2010-02-04 | 2010-03-24 | Ineos Healthcare Ltd | Composition |
GB201110520D0 (en) | 2011-05-10 | 2011-08-03 | Tate & Lyle Technology Ltd | Extraction of carboxylic acids with tin compounds |
US9539214B2 (en) | 2011-12-28 | 2017-01-10 | Pozen Inc. | Compositions and methods for delivery of omeprazole plus acetylsalicylic acid |
CN104971073B (zh) * | 2015-05-29 | 2018-01-12 | 西南药业股份有限公司 | 法莫替丁钙镁咀嚼片的制备方法及其产品 |
CN104906057B (zh) * | 2015-05-29 | 2018-03-02 | 西南药业股份有限公司 | 法莫替丁钙镁微丸型咀嚼片的制备方法及其产品 |
WO2017091166A1 (en) | 2015-11-26 | 2017-06-01 | Pharmacti̇ve İlaç San. Ve Ti̇c. A.Ş. | Stable pharmaceutical compositions and process for their preparation |
CN108712900A (zh) | 2015-12-19 | 2018-10-26 | 第时间美国泛型药物有限公司 | 软咀嚼片剂药物制剂 |
US20190022013A1 (en) | 2015-12-19 | 2019-01-24 | First Time Us Generics Llc | Soft-chew tablet pharmaceutical formulations |
AU2019259791B2 (en) * | 2018-04-27 | 2024-03-28 | Johnson & Johnson Consumer Inc. | Liquid oral pharmaceutical dosage form |
US11141375B2 (en) | 2018-10-18 | 2021-10-12 | Johnson & Johnson Consumer Inc. | Soft chewable dosage form |
KR102484953B1 (ko) * | 2020-06-25 | 2023-01-06 | 주식회사 인트로바이오파마 | 파모티딘, 수산화마그네슘, 및 침강탄산칼슘을 유효성분으로 하는 위장질환 치료용 필름코팅정제 |
CN112294841A (zh) * | 2020-10-21 | 2021-02-02 | 北京鑫开元医药科技有限公司 | 一种法莫替丁枸橼酸铋钾复方组合物、制备方法及其应用 |
CA3214612A1 (en) | 2021-03-24 | 2022-09-29 | Johnson & Johnson Consumer Inc. | A pharmaceutical composition comprising famotidine |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3048526A (en) * | 1958-08-04 | 1962-08-07 | Wander Company | Medicinal tablet |
FR2236483B1 (es) * | 1973-07-12 | 1976-11-12 | Choay Sa | |
US4198390A (en) * | 1979-01-31 | 1980-04-15 | Rider Joseph A | Simethicone antacid tablet |
JPS6056143B2 (ja) * | 1979-08-02 | 1985-12-09 | 山之内製薬株式会社 | アミジン誘導体ならびにその製造法 |
DE3710462A1 (de) * | 1987-03-30 | 1988-10-13 | Heumann Pharma Gmbh & Co | Pharmazeutische zubereitung zur behandlung von erkrankungen des magen-darm-traktes |
KR960011236B1 (ko) * | 1987-05-08 | 1996-08-21 | 스미스 클라인 앤드 프렌취 라보라토리스 리미티드 | 제약학적 조성물 및 고체 제형 |
ATE73328T1 (de) * | 1987-05-08 | 1992-03-15 | Smith Kline French Lab | Pharmazeutische zusammensetzungen. |
DK469989D0 (da) * | 1989-09-22 | 1989-09-22 | Bukh Meditec | Farmaceutisk praeparat |
US5075114A (en) * | 1990-05-23 | 1991-12-24 | Mcneil-Ppc, Inc. | Taste masking and sustained release coatings for pharmaceuticals |
EP0533770A1 (en) * | 1990-06-22 | 1993-03-31 | Beecham Group p.l.c. | Novel treatment |
US5260072A (en) * | 1990-08-30 | 1993-11-09 | Mcneil-Ppc, Inc. | Rotogranulations and taste masking coatings for preparation of chewable pharmaceutical tablets |
CA2052679C (en) * | 1990-08-30 | 1997-12-02 | Edward J. Roche | Rotogranulations and taste masking coatings for preparation of chewable pharmaceutical tablets |
US5229137A (en) * | 1992-05-06 | 1993-07-20 | Brigham And Women's Hospital, Inc. | Methods and pharmaceutical compositions for treating episodic heartburn |
-
1993
- 1993-11-30 CA CA002110313A patent/CA2110313C/en not_active Expired - Lifetime
- 1993-12-01 GR GR930100475A patent/GR1002397B/el not_active IP Right Cessation
- 1993-12-01 ES ES93309611T patent/ES2108234T3/es not_active Expired - Lifetime
- 1993-12-01 EP EP93309611A patent/EP0600725B1/en not_active Expired - Lifetime
- 1993-12-01 DE DE69313983T patent/DE69313983T2/de not_active Expired - Lifetime
- 1993-12-01 AT AT93309611T patent/ATE158176T1/de not_active IP Right Cessation
- 1993-12-01 DK DK93309611.7T patent/DK0600725T3/da active
-
1996
- 1996-11-25 US US08/756,080 patent/US5817340A/en not_active Expired - Lifetime
-
1997
- 1997-05-13 BR BR1100490-8A patent/BR1100490A/pt active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
BR1100490A (pt) | 2000-06-13 |
DE69313983D1 (de) | 1997-10-23 |
DE69313983T2 (de) | 1998-02-19 |
CA2110313C (en) | 2004-10-26 |
GR1002397B (el) | 1996-07-12 |
EP0600725A1 (en) | 1994-06-08 |
ATE158176T1 (de) | 1997-10-15 |
GR930100475A (el) | 1994-08-31 |
DK0600725T3 (da) | 1998-03-16 |
CA2110313A1 (en) | 1994-06-02 |
EP0600725B1 (en) | 1997-09-17 |
US5817340A (en) | 1998-10-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2108234T3 (es) | Composicion farmaceutica que contiene un guanidinotiazol y antiacidos. | |
ES2112387T3 (es) | Composiciones farmaceuticas que contienen simeticona para el tratamiento de problemas gastrointestinales. | |
IT8248908A0 (it) | Composizione farmaceutica per la somministrazione per via orale dicomposti che debbono essere assorbiti nell'intestino crasso | |
ES2040232T3 (es) | Preparaciones medicinales para administracion oral conteniendo una sola dosis de 10 a 240 mg de dihidropiridina. | |
HK79390A (en) | Pharmaceutical compositions containing pharmacologically active biphosphonates | |
ES2188782T3 (es) | Formulaciones farmaceuticas que contienen darifenacina. | |
AR011114A1 (es) | COMPOSICIoN FARMACÉUTICA LIBRE DE LACTOSA EN FORMA GRANULADA O EN MEZCLA PARA EL TRATAMIENTO DE DESoRDENES INDUCIDOS POR HISTAMINA. | |
CO5160265A1 (es) | Esteres aminoacidos de ribavirina y composiciones farmaceuticas que los contienen . | |
ES2194210T3 (es) | Forma de dosificacion para suministrar una dosis ascendente de farmaco. | |
DK163959C (da) | Farmaceutisk praeparat til oral indgift indeholdende cimetidin | |
IL68456A (en) | Pharmaceutical compositions comprising perfluoro-substituted compounds as vehicles | |
ES2119748T3 (es) | Composicion farmaceutica que contiene un farmaco ligeramente soluble en agua. | |
ES8307496A1 (es) | Procedimiento para la obtencion de una preparacion galenica antagonista al calcio. | |
FI933975A0 (fi) | Tabletter som kontrollerat avgiver naproxen | |
IT1151953B (it) | Composizione farmaceutica per la cura di affezioni della cavita' orale | |
IT1241079B (it) | Composizioni farmaceutiche contenenti ipriflavone,procedimento per la loro preparazione e relativo impiego terapeutico | |
IT1187743B (it) | Composizioni farmaceutiche a base di destrorfano per applicazione instranasale | |
DE3380165D1 (en) | Analgesic combinations | |
MX9302832A (es) | Nuevo medicamento para el tratamiento de la arritmia. | |
AR002946A1 (es) | Un conjunto para uso en el tratamiento o la prevencion de la osteoporosis en los mamiferos de acuerdo con una dieta ciclica. | |
IT1238070B (it) | Composizione farmaceutica per la protezione della mucosa gastro duodenale | |
IT8224219A0 (it) | Composizione farmaceutica per la somministrazione orale di calcitonina. | |
IT1170255B (it) | Composizione farmaceutica per la somministrazione orale di calcitonina | |
GT198800032A (es) | Formas de dosificacion oral,realzando la absorcion de acidosy sales quenodeoxicolico y deoxicolico. | |
MX9204711A (es) | Compuestos terapeuticos. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 600725 Country of ref document: ES |